Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first‐line treatment

Trifluridine/tipiracil (FTD/TPI) is an orally administrated anticancer drug with efficacy validated for patients with metastatic colorectal cancer (mCRC) or gastric cancer. FTD, a key component of FTD/TPI, exerts antitumor effects via its incorporation into DNA. Using specific antibodies against bro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Yoshiaki, Oki, Eiji, Qiu, Shichao, Nakanishi, Ryota, Makiyama, Akitaka, Miyamoto, Yuji, Kotaka, Masahito, Shimokawa, Mototsugu, Ando, Koji, Kimura, Yasue, Kitao, Hiroyuki, Maehara, Yoshihiko, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177777/
https://www.ncbi.nlm.nih.gov/pubmed/33780084
http://dx.doi.org/10.1111/cas.14904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177777/
https://www.ncbi.nlm.nih.gov/pubmed/33780084
http://dx.doi.org/10.1111/cas.14904

Ejemplares similares